0
Is olaparib the only PARP inhibitor that has been approved?
- 1 people answered
0 Vote
1 Contributor
1940 Views 
0 Saved
0 Vote 1 Contributor1940 Views 0 SavedYou might also be interested in
If you’re looking for a good oncologist in Hyderabad, some well-known names include Dr. Sumanth Kumar Mallupattu, Dr. Vishal Toka, and Dr. T Vishal. They are experienced in diagnosing and treating various types of cancers and are known for their patient-friendly approach. Many patients trust them fo....
Hello, please describe your problem in detail, then only we'll be able to provide you treatment costs. You can call us on +91-8010994994 and talk to our medical expert.
Some cancer treatments, like chemotherapy or radiation, can cause side effects like nausea or fatigue, but it’s not the same for everyone. If you’re feeling sick, talk to your doctor—they can prescribe medicines to help with nausea or suggest lifestyle tips to boost your energy. Eating small, freque....
Rahul Sharma
Yes, PARP inhibitors are relatively newer class of drugs and scientists have just begun to explore their functionality and usage in Cancer treatment. LYNPARZA is the first and only PARP inhibitor approved in 2 distinct settings: For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in complete or partial response to platinum-based chemotherapy. For the treatment of adult patients with suspected deleterious germline BRCA-mutated advanced ovarian cancer which has been treated with 3 or more prior lines of chemotherapy. Patients should be selected for therapy based on an FDA-approved companion diagnostic for LYNPARZA. Poly (ADP-ribose) Polymerase, or PARP, enzymes mediate DNA repair by transferring ADP-ribose units to preexisting ADP-ribose chains on proteins and to proteins. This ADP–ribosylation process recruits DNA repair enzymes, thereby maintaining genomic integrity. Inhibiting this process can lead to the accumulation of DNA damage and, ultimately, cell death.